These findings are consistent with the hypothesis that H202 of AM origin contributes to the development of emphysema in smokers.
Introduction
At present it is believed that emphysema develops as a consequence of protease-antiprotease imbalance in the lung. This proteolytic theory has evolved after the recognition of an association between severe deficiency of&'-proteinase inhibitor and the development of panacinar emphysema [l] and the observations that emphysema can be induced by instillation of elastolytic enzymes into the lower respiratory tract in animals [2, 3] . It is thought that the alveolar structures are normally protected from extracellular proteases, which can originate from inflammatory cells, by an antiprotease screen. At the alveolar level al-proteinase inhibitor is the principal antiprotease [4] but it can be inhibited by oxidation of the methionine that is part of the molecular structure in or near the active site [5] . Thus, in the presence of oxidants, a functional deficiency of cul-proteinase inhibitor may occur in the lower respiratory tract, disturbing the protease-antiprotease balance in favour of protease activity. Cigarette smoking has been shown to induce functional antiprotease deficiency in the lower respiratory tract [6] . This may be due to a direct action of oxidants in cigarette smoke [7] but cigarette smoking also enhances the oxidative metabolic response of alveolar macrophages (AM) [8] and might, therefore, promote release from these cells of hydrogen peroxide (H203 and other oxidants that are important for the cells' microbicidal functions [9] . Such release of AM-derived oxidants might lead to functional inhibition of al-proteinase inhibitor in the microenvironment of these cells. We have therefore measured the extracellular release of MzOz from human AM and examined the influences of the macrophage donors' smoking habits and pulmonary diseases.
Methods

Alveolar macrophages
These were obtained by bronchoalveolar lavage [lo] 
Statistical analyses
Comparison of H202 release by smokers' and non-smokers' AM was performed by using Student's t-test for unpaired data. Comparison of H202 release by AM from donors with different diseases, taking into account the donors' smoking habits, was performed by analysis of covariance.
Results
After 72 h culture Giemsa staining showed AM monolayers to be free of other cell types. The AM were >95% viable as judged by trypan blue exclusion. Unstimulated AM released minimal quantities of H202 (<0.2 nmol h-' pg-' of DNA). However, on stimulation with PMA this was markedly enhanced (0.2-8.73 nmol h-' pg-' of DNA). PMAstimulated AM from smokers released more H202 (3.83 nmol h-' pg-' of DNA; SEM 0.44; n = 24) than PMA-stimulated AM from non-smokers (2.33 nmol h-' pg-' of DNA; SEM 0.40; n = 17). The difference was significant (P < 0 .05). Age and sex of the AM donors had no influence in the quantity of Hz02 released. However, some diseases of the donors did affect the H202 release, even when allowance was made for smoking habits (Table 1 ; Fig. 1 ) . AM from patients with a recent lower respiratory tract infection released more H202 (5.22 nmol h-' pg-' of DNA) on stimulation as did AM from patients with non-bronchial malignancies (4.70 nmol h-' pg-' of DNA). The difference was significant (P< 0.01) in both instances.
Discussion
Our results show that AM from cigarette smokers, when stimulated, released significantly greater quantities of H202 into the extracellular environment than AM from non-smokers. These results accord with those of other workers who, by measuring release of superoxide, have shown similar enhancements of AM oxidative metabolism for young asymptomatic cigarette smokers [8] and for smokeexposed rats [14] . The unstimulated AM released minimal quantities of H20z, indeed, for AM from all but three patients (all smokers) the basal levels of release were below the lower limit of sensitivity of our assay (< 0.2 nmol h-' pg-' of DNA); thus it was not possible to determine whether unstimulated AM from smokers released greater quantities of H202 than the AM of nonsmokers. Nevertheless, in vivo, AM will be subject to frequent phagocytic stimulation. We chose PMA as our receptor-mediated [15] phagocytic stimulus [16] in view of its degree of cellular stimulation, repeatability of results and convenience of use.
Our interpretation of the data for H202 release from stimulated AM is made cautiously since numbers of smokers and non-smokers in the various disease groups were not matched (Fig. 1) . However, even if the disease group that contributes most to the high value for the smokers (recent lower respiratory tract infection) is removed from analysis, smokers' AM still release significantly greater quantities of H202 than the AM of non-smokers (3.1 k 0.4 nmol h-' pg-' of DNA vs 2.3 f 0.4). This implies that the effects of smoking and infection might be cumulative but whether infection would have an. effect in non-smokers cannot be assessed from the data. The mechanisms by which the enhancement of release of H202 from smokers' macrophages occurs are not known. Clearly one or more components of cigarette smoke may directly affect the AM. A more intriguing possibility is that smokers' AM have been primed for enhanced responses by pulmonaly lymphocytes or lymphocyte products as part of a cellmediated immune response. In support of this hypothesis two of the five patients with nonbronchial malignancies (one Hodgkin's disease and one disseminated thyroid carcinoma) and one patient with bronchiectasis had significant elevation of the percentage of lymphocytes in their bronchoalveolar cells (24.0, 45.6 and 33.6% respectively). We have shown [17] that AM, in vitro, can be primed by lymphokines for an enhanced H202 release on stimulation. There would be ample opportunity in vivo for cell-mediated immunity to be developed against antigenic components of cigarette smoke or bacterial antigens. We suggest that in vivo priming of AM bypulmonary lymphocytes also explains the enhanced H202 release by cells from donors with recent lower respiratory tract infections or with non-bronchial malignancies (an heterogeneous group including disseminated nasopharyngeal and thyroid carcinomata and pulmonary lymphomas). In these groups the presumptive cell-mediated immunity would be in response to microbial and tumour antigens respectively.
Irrespective of the mechanisms underlying the macrophage activation the enhanced release of H202 may result in a functional deficiency of al-proteinase inhibitor in the microenvironment around AM, thus locally favouring uninhibited protease activity [18, 19] . In addition Hz02 may itself be directly tissue-toxic [20] . Thus our findings sustain the possibility that H202 of macrophage origin might contribute to the development of emphysema by smokers.
